Latest news, press releases, and SEC filings for Ligand Pharmaceuticals Inc (LGNZZ) https://caymanjournal.com/stock/LGNZZ en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 04:32:07 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 ⚠️ ATTENTION: Filing Data Missing ⚠️ Please note: You provided the metadata for an SEC filing (LIGAND PHARMACEUTICALS INC, ARS) but did not include the actual content of the PDF document. To provide the comprehensive, expert analysis you requested, I need the text or the PDF document itself. Once https://caymanjournal.com/stock/LGNZZ/sec-filing/0000886163-26-000023 https://caymanjournal.com/stock/LGNZZ/sec-filing/0000886163-26-000023 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing # 📜 What This Document Is ℹ️ This document is a **Proxy Statement (DEF 14A)**. Think of it as the official instruction manual and corporate report card for an annual shareholder meeting. It's filed with the SEC and is mandatory for Ligand Pharmaceuticals Incorporated ("Ligand") to provide all of it https://caymanjournal.com/stock/LGNZZ/sec-filing/0000886163-26-000021 https://caymanjournal.com/stock/LGNZZ/sec-filing/0000886163-26-000021 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing